LIAROZOLE DIHYDROCHLORIDE
|
|
- CAS號:
- 1883548-96-6
- 英文名:
- LIAROZOLE DIHYDROCHLORIDE
- 英文別名:
- R75251 dihydrochloride;LIAROZOLE DIHYDROCHLORIDE;Liarozole dihydrochloride >=98% (HPLC)
- 中文名:
- LIAROZOLE DIHYDROCHLORIDE
- 中文別名:
- 化合物 T11847;化合物 LIAROZOLE DIHYDROCHLORIDE
- CBNumber:
- CB04740469
- 分子式:
- C17H14Cl2N4
- 分子量:
- 345.23
- MOL File:
- 1883548-96-6.mol
|
|
|
LIAROZOLE DIHYDROCHLORIDE化學(xué)性質(zhì)
-
儲存條件:
-
room temp
-
|
-
溶解度:
-
Water: ≥ 50 mg/mL (131.00 mM); DMSO: 50 mg/mL (131.00 mM)
-
|
-
形態(tài):
-
powder
-
|
-
顏色:
-
white to beige
-
|
-
水溶解性:
-
H2O: 2mg/mL, clear
-
|
LIAROZOLE DIHYDROCHLORIDE性質(zhì)、用途與生產(chǎn)工藝
Liarozole dihydrochloride (R75251; R85246) 是一種細胞色素 P450 (CYP450) 依賴性抑制劑,具有口服活性,也是雌激素 (estrogen) 和睪丸雄激素合成的有效抑制劑。Liarozole dihydrochloride 通過抑制 4-羥化酶 (4-hydroxylase) 來防止視黃酸的分解代謝,并在體內(nèi)顯示出類視黃醇保留和類視黃醇模擬作用。Liarozole dihydrochloride 是咪唑衍生物; 它被作為前列腺癌和和皮膚病的非激素藥物進行研究。
Liarozole inhibits the metabolism of retinoic acid to more polar metabolites in hamster liver microsomes (IC
50
=2.2 μM), rat liver homogenate (IC
50
=0.14 μM), dunning prostate cancer homogenate (IC
50
=0.26 μM) and MCF-7 human breast cancer cells (almost complete block at 10μM) .
Liarozole inhibits 17a-hydroxylase activity in bovine adrenal microsomes (IC
50
=0.15 μM) .
Liarozole has modest inhibitory activity on cholesterol synthesis in human hepatoma cells(IC
50
=5 μM).
LIAROZOLE DIHYDROCHLORIDE
上下游產(chǎn)品信息
上游原料
下游產(chǎn)品
更新日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS編號 | 包裝 | 價格 |
---|
2025/05/22 | HY-106019C | Liarozole dihydrochloride | 1883548-96-6 | 5 mg | 1500元 |
2025/05/22 | HY-106019C | Liarozole dihydrochloride | 1883548-96-6 | 10 mg | 2400元 |
LIAROZOLE DIHYDROCHLORIDE
生產(chǎn)廠家
1883548-96-6, LIAROZOLE DIHYDROCHLORIDE 相關(guān)搜索:
- 抑制劑
- 化合物 LIAROZOLE DIHYDROCHLORIDE
- 化合物 T11847
- 1883548-96-6
- Liarozole dihydrochloride >=98% (HPLC)
- R75251 dihydrochloride
- LIAROZOLE DIHYDROCHLORIDE